Jan 19, 2026
1:100
For every 100 shares held, investors received 1. The price per share adjusted from $0.44 to $44.00.
The split itself did not change the total investment value.
Oncoinvent ASA (OSL:ONCIN) operates in the Pharmaceuticals: major industry.
Oncoinvent ASA company overviewOncoinvent ASA's most recent stock split was on January 19, 2026. It was a 1-for-100 reverse split, so shareholders received 1 share for every 100 they held.
Oncoinvent ASA (OSL:ONCIN) has split its stock 5 times: a 253-for-250 split on May 5, 2020, a 2179-for-250 split on May 23, 2023, a 1-for-100 reverse split on May 30, 2024, a 671-for-430 split on November 12, 2025, and a 1-for-100 reverse split on January 19, 2026.
Oncoinvent ASA has split its stock 5 times. This history records 5 splits between May 5, 2020 and January 19, 2026.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Oncoinvent ASA's 1-for-100 reverse split on January 19, 2026, every 100 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Oncoinvent ASA has not announced a new split in our records. Its most recent split was on January 19, 2026, less than a year ago. Companies announce splits in advance, and any new OSL:ONCIN split will appear on this page.
Already premium?